Skip to content

AARD AARD CapEx

CapEx at other companies

AbbVie logo
AbbVieABBV
$265M+12.8%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$52K-61.5%
Arvinas logo
ArvinasARVN
$1.3M+225%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$215K-60.6%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$0-100%

Other financials

Income statement

See full
Revenue-
Operating income-$22.5M-115%
Net income-$21.6M-132%
EPS (diluted)-$0.99-39.4%

Balance sheet

See full
Cash & equivalents$62.4M+136%
Total debt$336.0K-53.7%
Total equity$87.0M-42.3%
Total assets$98.6M-37.2%

Cash flow

See full
Operating cash flow-$18.9M-65.7%
Free cash flow-$16.8M-117%

Valuation

See full
Market cap$124.35M-58.6%
Enterprise value$62.25M-77.4%

Returns & leverage

See full
Return on equity-58.8%
Debt / equity0.0×
Current ratio8.1×-17.8×

Where this comes from

Reported directly by AARD in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: AARD’s 10-K, filed March 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AARD's capex?
AARD (AARD) reported capex of $0 in Q4 2025.
How has AARD's capex changed year-over-year?
AARD's capex decreased by 100.0% year-over-year, from $6K to $0.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.